Barclays PLC Treace Medical Concepts, Inc. Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Barclays PLC holds 17,623 shares of TMCI stock, worth $102,213. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,623
Previous 41,046
57.07%
Holding current value
$102,213
Previous $535,000
77.94%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TMCI
# of Institutions
129Shares Held
39.5MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$31.1 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$23.6 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$21.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$21 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.83MShares$16.4 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $321M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...